vTv Therapeutics Inc.

vTv Therapeutics Inc.verified

VTVT

Price:

$13.87

Market Cap:

$36.23M

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approac...[Read more]

Industry

Biotechnology

IPO Date

2015-07-30

Stock Exchange

NASDAQ

Ticker

VTVT

The PE Ratio as of December 2024 (TTM) for vTv Therapeutics Inc. (VTVT) is -3.17

According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.17. This represents a change of -22.65% compared to the average of -4.10 of the last 4 quarters.

vTv Therapeutics Inc. (VTVT) Historical PE Ratio (quarterly & annually)

How has VTVT PE Ratio performed in the past?

The mean historical PE Ratio of vTv Therapeutics Inc. over the last ten years is -3.42. The current -3.17 PE Ratio has changed 9.18% with respect to the historical average. Over the past ten years (40 quarters), VTVT's PE Ratio was at its highest in in the December 2020 quarter at 19.69. The PE Ratio was at its lowest in in the June 2021 quarter at -54.95.

Quarterly (TTM)
Annual

Average

-3.42

Median

-2.66

Minimum

-9.93

Maximum

-1.18

vTv Therapeutics Inc. (VTVT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of vTv Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 323.15%

Maximum Annual PE Ratio = -1.18

Minimum Annual Increase = -64.61%

Minimum Annual PE Ratio = -9.93

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.18-41.69%
2022-2.03-42.24%
2021-3.52-64.61%
2020-9.93323.15%
2019-2.35-43.71%
2018-4.1715.57%
2017-3.6127.98%
2016-2.8237.56%
2015-2.05-18.19%
2014-2.5134.91%

vTv Therapeutics Inc. (VTVT) Average PE Ratio

How has VTVT PE Ratio performed in the past?

The current PE Ratio of vTv Therapeutics Inc. (VTVT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.24

5-year avg

-3.80

10-year avg

-3.42

vTv Therapeutics Inc. (VTVT) PE Ratio vs. Peers

How is VTVT’s PE Ratio compared to its peers?

vTv Therapeutics Inc.’s PE Ratio is greater than Zura Bio Limited (-4.76), less than Apexigen, Inc. (-0.24), less than Phio Pharmaceuticals Corp. (-0.29), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Immix Biopharma, Inc. (-2.93), greater than Sigilon Therapeutics, Inc. (-16.76), less than NovaBay Pharmaceuticals, Inc. (-0.19), less than InMed Pharmaceuticals Inc. (-1.72), less than GeoVax Labs, Inc. (-0.60), less than Generation Bio Co. (-0.49), less than Kronos Bio, Inc. (-0.67), greater than Erasca, Inc. (-4.56), less than C4 Therapeutics, Inc. (-2.55), greater than Edgewise Therapeutics, Inc. (-22.36), less than Allarity Therapeutics, Inc. (-0.08), less than NeuroBo Pharmaceuticals, Inc. (-0.87), less than Hillstream BioPharma, Inc. (-0.99), less than Virax Biolabs Group Limited (-0.57), less than Quoin Pharmaceuticals, Ltd. (-0.28), less than Pyxis Oncology, Inc. (-1.69), less than Altamira Therapeutics Ltd. (-0.02), less than Elevation Oncology, Inc. (-0.79),

Build a custom stock screener for vTv Therapeutics Inc. (VTVT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

vTv Therapeutics Inc. (VTVT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is vTv Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for vTv Therapeutics Inc. (VTVT)?

What is the highest PE Ratio for vTv Therapeutics Inc. (VTVT)?

What is the 3-year average PE Ratio for vTv Therapeutics Inc. (VTVT)?

What is the 5-year average PE Ratio for vTv Therapeutics Inc. (VTVT)?

How does the current PE Ratio for vTv Therapeutics Inc. (VTVT) compare to its historical average?